SO
UBX

STRS Ohio’s Unity Biotechnology UBX Stock Holding History

STRS Ohio’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10
Closed – – 2434
2021
Q1 		$0 Hold
10
– – ﹤0.01% 2283
2020
Q4 		$0 Sell
10
-6,080
-100% -$293K ﹤0.01% 2282
2020
Q3 		$210K Buy
6,090
+6,070
+30,350% +$384K ﹤0.01% 1652
2020
Q2 		$1K Hold
20
– – ﹤0.01% 2148
2020
Q1 		$1K Hold
20
– – ﹤0.01% 2007
2019
Q4 		$1K Sell
20
-130
-87% -$9.17K ﹤0.01% 2050
2019
Q3 		$9K Hold
150
– – ﹤0.01% 2026
2019
Q2 		$14K Hold
150
– – ﹤0.01% 2057
2019
Q1 		$12K Hold
150
– – ﹤0.01% 2000
2018
Q4 		$24K Hold
150
– – ﹤0.01% 1975
2018
Q3 		$24K Hold
150
– – ﹤0.01% 2024
2018
Q2 		$22K Buy
+150
New +$21.9K ﹤0.01% 2054

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

STRS Ohio's UBX Position: Q2 2021 in Review

STRS Ohio sold out of Unity Biotechnology (UBX) in Q2 2021, closing a stake of 10 shares.

STRS Ohio first reported a position in UBX in Q2 2018 and held it in 12 quarters. The position peaked at $210K in Q3 2020. 98 funds tracked by Wall St. Rank hold UBX as of Q2 2021.

  • STRS Ohio reported no remaining Unity Biotechnology position as of Q2 2021 after selling out during the quarter.
  • STRS Ohio sold 10 Unity Biotechnology shares in Q2 2021.
  • STRS Ohio first reported a position in Unity Biotechnology in Q2 2018 and held it in 12 quarters.
  • STRS Ohio's Unity Biotechnology position peaked at $210K in Q3 2020.
  • 98 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.